Trial Profile
SCOLTA: Surveillance Cohort Long-Term Toxicity Antiretrovirals (Stribild cohort)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Adverse reactions
- Acronyms SCOLTA
- 16 Feb 2017 Results (n=1154) of SCOLTA-HCV project presented at the 24th Conference on Retroviruses and Opportunistic Infections.
- 02 Jan 2017 New trial record